The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_005633.3(SOS1):c.3322G>A (p.Asp1108Asn)

CA1624224

240197 (ClinVar)

Gene: SOS1
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 57a75218-590b-421b-8f2f-c7254ed50eaa
Approved on: 2020-06-25
Published on: 2020-06-25

HGVS expressions

NM_005633.3:c.3322G>A
NM_005633.3(SOS1):c.3322G>A (p.Asp1108Asn)
ENST00000395038.6:c.3322G>A
ENST00000402219.6:c.3322G>A
ENST00000426016.5:c.3322G>A
NC_000002.12:g.38995147C>T
CM000664.2:g.38995147C>T
NC_000002.11:g.39222288C>T
CM000664.1:g.39222288C>T
NC_000002.10:g.39075792C>T
NG_007530.1:g.130317G>A
More

Likely Benign

Met criteria codes 2
BP5 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.3322G>A (p.Asp1108Asn) variant in SOS1 was present in 0.039% (10/13658 with 95% CI) of Latino alleles in gnomAD v3 (BS1). This variant has been identified in a patient with Noonan syndrome who had an alternate molecular basis for disease (BP5; SCV000966758.1; ClinVar ID: 44603). It was also identified in a homozygous state in an individual who also carried a variant in TRMT1 (BP5 not met; Baylor College of Medicine internal data). In summary, this variant meets criteria to be classified as likely benign. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): BS1, BP5.
Met criteria codes
BP5
ClinVar ID: 44603
BS1
Present in 0.0058% (2/6118) of “Other” alleles and 0.0039% (4/34572) Latino in gnomAD v2.1.1 Present in 0.039% (10/13658) of Latino alleles in gnomAD v3
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.